DiaMedica Therapeutics Inc. Quarterly Marketable Securities, Current in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
DiaMedica Therapeutics Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2019 to Q2 2024.
  • DiaMedica Therapeutics Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $40M, a 15.8% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $40M +$5.46M +15.8% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $44.4M +$17.9M +67.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $48.4M +$19.6M +68% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $44.2M +$10.9M +32.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $34.5M -$852K -2.41% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $26.5M -$11.5M -30.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $28.8M -$11.6M -28.8% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $33.3M +$1.44M +4.5% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $35.4M +$16.3M +85.6% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $38M +$17.9M +89.4% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $40.4M +$20.3M +101% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $31.9M +$11.1M +53.1% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $19.1M +$12.2M +179% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $20.1M +$10.7M +115% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $20.1M +$16.1M +403% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $20.8M +$15.8M +316% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $6.84M -$1.15M -14.4% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $9.35M -$1.61M -14.7% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $4M Dec 31, 2019 10-K 2021-03-10
Q3 2019 $5M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $7.99M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $11M Mar 31, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.